Bioventus Inc (BVS)
11.45
-0.06
(-0.52%)
USD |
NASDAQ |
Nov 22, 10:45
Bioventus Shareholders Equity (Quarterly): 148.74M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 148.74M |
| June 30, 2024 | 150.94M |
| March 31, 2024 | 171.28M |
| December 31, 2023 | 173.59M |
| September 30, 2023 | 177.53M |
| June 30, 2023 | 183.20M |
| March 31, 2023 | 188.51M |
| December 31, 2022 | 325.24M |
| September 30, 2022 | 343.40M |
| June 30, 2022 | 447.98M |
| Date | Value |
|---|---|
| March 31, 2022 | 449.78M |
| December 31, 2021 | 458.92M |
| September 30, 2021 | 152.50M |
| June 30, 2021 | 141.56M |
| March 31, 2021 | 142.39M |
| December 31, 2020 | 144.16M |
| September 30, 2020 | 143.22M |
| December 31, 2019 | 142.98M |
| March 31, 2016 | 186.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
141.56M
Minimum
Jun 2021
458.92M
Maximum
Dec 2021
226.99M
Average
172.43M
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp | 20.71B |
| Insulet Corp | 1.118B |
| Perspective Therapeutics Inc | 328.47M |
| Xtant Medical Holdings Inc | 45.72M |
| Catheter Precision Inc | 12.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 769.49M |
| Total Liabilities (Quarterly) | 582.66M |
| Debt to Equity Ratio | 2.579 |
| Current Ratio | 1.412 |
| Net Debt Paydown Yield | 0.06% |